Phacilitate

  • About Us
  • Insights and Resources
        • All Insights and Resources
          The latest and greatest Insights Phacilitate has to offer, across all our key sectors and mediums

        • Webinar Library
          View upcoming and past webinars about world of advanced therapies

           

          The Phacilitate Podcast
          Insightful conversations with industry leaders

        • Content Services
          We create game-changing content that empowers the advanced therapies industry

          • Industry Insights
            • Clinical Trials
            • Collaborations, Mergers and Acquisitions
            • Finance and Investment
            • GMP
            • Patient Access and Engagement
            • Regulatory and Standards
            • Reimbursement
            • Strategy
          • Manufacturing
            • Automation and Digitisation
            • Characterisation
            • CMC
            • GMP
            • Logistics
            • Partnering
            • Point of Care
            • Raw Materials
            • Scaling Up
            • Skills, Talent and Development
            • Supply Chain
          • Techniques
            • Allogeneic
            • Autologous
            • CAR-X
            • Cell Therapy
            • Gene Editing
            • Gene Therapy
            • NKx
            • Stem Cells
            • Viral/Non-viral Vectors
  • Events
  • Membership
    • Phacilitate Network
    • Women in Advanced Therapies
  • Latest News
  • Contact Us
Back
  • About Us
  • Insights and Resources
        • All Insights and Resources
          The latest and greatest Insights Phacilitate has to offer, across all our key sectors and mediums

        • Webinar Library
          View upcoming and past webinars about world of advanced therapies

           

          The Phacilitate Podcast
          Insightful conversations with industry leaders

        • Content Services
          We create game-changing content that empowers the advanced therapies industry

          • Industry Insights
            • Clinical Trials
            • Collaborations, Mergers and Acquisitions
            • Finance and Investment
            • GMP
            • Patient Access and Engagement
            • Regulatory and Standards
            • Reimbursement
            • Strategy
          • Manufacturing
            • Automation and Digitisation
            • Characterisation
            • CMC
            • GMP
            • Logistics
            • Partnering
            • Point of Care
            • Raw Materials
            • Scaling Up
            • Skills, Talent and Development
            • Supply Chain
          • Techniques
            • Allogeneic
            • Autologous
            • CAR-X
            • Cell Therapy
            • Gene Editing
            • Gene Therapy
            • NKx
            • Stem Cells
            • Viral/Non-viral Vectors
  • Events
  • Membership
    • Phacilitate Network
    • Women in Advanced Therapies
  • Latest News
  • Contact Us
Join Today
Sign In
Sign In
Join Today
  • All Insights and Resources
  • Industry Insights
  • Manufacturing
  • Techniques
Clinical Trials
Collaborations, Mergers and Acquisitions
Finance and Investment
GMP
Patient Access and Engagement
Regulatory and Standards
Reimbursement
Strategy
Automation and Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent and Development
Supply Chain
Allogeneic
Autologous
CAR-X
Cell Therapy
Gene Editing
Gene Therapy
NKx
Stem Cells
Viral/Non-viral Vectors
All News

GMP

Aldevron Launches Eureca-V MAD7 at Advanced Therapies Week
20 January 2023
Aldevron Launches Eureca-V MAD7 at Advanced Therapies Week
Global leader in custom development
MicrofluidX Announces Partnership with CCRM for End-to-End Bioprocessing of CAR-T
19 January 2023
MicrofluidX Announces Partnership with CCRM for End-to-End Bioprocessing of CAR-T
UK-based provider of next-generation bioreactors
Avectas Launches Solupore® Non-Viral Platform for Engineering Cells at Advanced Therapies Week
18 January 2023
Avectas Launches Solupore® Non-Viral Platform for Engineering Cells at Advanced Therapies Week
The Solupore® platform looks to
Excellos Announces the Launch of ‘Excellos 360’ Technology at Advanced Therapies Week
18 January 2023
Excellos Announces the Launch of ‘Excellos 360’ Technology at Advanced Therapies Week
Excellos 360 will employ the
POPULAR NEWS ITEMS
Image
3 February 2023

Navigating the Applications of Title21’s Manufacturing Execution System

Image
2 February 2023

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image
1 February 2023

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

ReiThera Opens New Large-Scale Viral Vector Manufacturing Facility
10 January 2023
ReiThera Opens New Large-Scale Viral Vector Manufacturing Facility
Leading contract development and manufacturing
Charles River Expands Cell Therapy CDMO Capacity
5 January 2023
Charles River Expands Cell Therapy CDMO Capacity
International pharmaceutical developer Charles River
Merit Complete UK’s First CAR-T Cell Manufacturing Facility for Autolus Therapeutics
20 December 2022
Merit Complete UK’s First CAR-T Cell Manufacturing Facility for Autolus Therapeutics
Leading offsite engineering and construction
A Novel Technology for AAV Manufacture: TESSA™ in the Spotlight
15 December 2022
A Novel Technology for AAV Manufacture: TESSA™ in the Spotlight
Over the past year or
Load more News
RECOMENDED TOPICS
Automation & Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent & Development
Supply Chain
POPULAR NEWS ITEMS
Image

Navigating the Applications of Title21’s Manufacturing Execution System

Image

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

logo_footer
logo_mobile_footer
Company
  • About Us
  • Events
  • Contact Us
Resources
  • Insights and Resources
  • Latest News
  • Phacilitate Podcast
  • Content Services
Network
  • Sign In
  • Join Today
social_icon Linkedin
social_icon Twitter

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

  • Privacy Policy
  • Code of Conduct
  • Terms & Conditions
  • Cookies
Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022